Dr. Litzow is Professor of Medicine in the Division of Hematology at Mayo Clinic in Rochester, Minnesota. He was the Director of the BMT Program at Mayo from 1992 to 2008 and continues to remain active in the BMT program. He was the Director of the Myeloid Disease Oriented Group in the Division of Hematology from 2002 to 2016. He was appointed chair of the Leukemia Committee of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) in September 2013 after having served as co-chair of the committee since 2001.
Maxim Norkin, MD, PhD, is board certified in hematology and oncology with clinical expertise in hematological malignancies and bone marrow transplantation. An advisory group member of the National Marrow Donor Program, Dr.
Dr. Nimer has been conducting extensive clinical and basic science research into the treatment, and genetic basis of adult leukemia and
Dr. Luskin received her MD from the University of Pennsylvania Perelman School of Medicine in 2009. She completed residency training in Internal Medicine at Brigham and Women's Hospital, followed by a fellowship in Hematology and Oncology at the University of Pennsylvania. She joined Dana-Farber as a member of the Adult Leukemia program in 2016.
Melhem Solh, M.D., is board certified in the subspecialties of medical oncology and hematology. Dr. Solh is a Northside Hospital Blood and Marrow Transplant and Leukemia Program physician.In 2019, Dr. Solh was recognized as among Atlanta’s Top Doctors in his specialty by Castle Connolly.
Saurabh Chhabra, MD, received his Medical Degree from the University of Delhi in 2002. He completed his Internal Medicine Residency at Rutgers-Robert Wood Johnson Medical School in New Brunswick, NJ in 2008. He then went on to complete his Fellowship in Hematology/Oncology at Cancer Institute of New Jersey in 2011. Dr. Chhabra then moved to Stanford University, Stanford, CA and completed his Fellowship in Blood and Marrow Transplantation in 2012.